These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 16962979)

  • 21. Liposomal amphotericin B for the treatment of visceral leishmaniasis.
    Bern C; Adler-Moore J; Berenguer J; Boelaert M; den Boer M; Davidson RN; Figueras C; Gradoni L; Kafetzis DA; Ritmeijer K; Rosenthal E; Royce C; Russo R; Sundar S; Alvar J
    Clin Infect Dis; 2006 Oct; 43(7):917-24. PubMed ID: 16941377
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Visceral leishmaniasis in patients with HIV infection].
    Ribera E; Cucurull E; Ocaña I; Vallespí T; Gasser I; Juste C
    Enferm Infecc Microbiol Clin; 1995 Feb; 13(2):73-9. PubMed ID: 7711130
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Leishmania / HIV co-infections.
    Desjeux P
    Afr Health; 1995 Nov; 18(1):20-2. PubMed ID: 12290565
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical use of polymerase chain reaction performed on peripheral blood and bone marrow samples for the diagnosis and monitoring of visceral leishmaniasis in HIV-infected and HIV-uninfected patients: a single-center, 8-year experience in Italy and review of the literature.
    Antinori S; Calattini S; Longhi E; Bestetti G; Piolini R; Magni C; Orlando G; Gramiccia M; Acquaviva V; Foschi A; Corvasce S; Colomba C; Titone L; Parravicini C; Cascio A; Corbellino M
    Clin Infect Dis; 2007 Jun; 44(12):1602-10. PubMed ID: 17516404
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High levels of anti-Leishmania IgG3 and low CD4
    Kuschnir RC; Pereira LS; Dutra MRT; de Paula L; Silva-Freitas ML; Corrêa-Castro G; da Costa Cruz Silva S; Cota G; Santos-Oliveira JR; Da-Cruz AM
    BMC Infect Dis; 2021 Apr; 21(1):369. PubMed ID: 33874901
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical aspects of visceral leishmaniasis in HIV infection.
    Jarvis JN; Lockwood DN
    Curr Opin Infect Dis; 2013 Feb; 26(1):1-9. PubMed ID: 23221770
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Single-dose liposomal amphotericin B in the treatment of visceral leishmaniasis in India: a multicenter study.
    Sundar S; Jha TK; Thakur CP; Mishra M; Singh VP; Buffels R
    Clin Infect Dis; 2003 Sep; 37(6):800-4. PubMed ID: 12955641
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Amphotericin B colloidal dispersion for the treatment of Indian visceral leishmaniasis.
    Sundar S; Mehta H; Chhabra A; Singh V; Chauhan V; Desjeux P; Rai M
    Clin Infect Dis; 2006 Mar; 42(5):608-13. PubMed ID: 16447104
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Plasma lipoproteins in visceral leishmaniasis and their effect on Leishmania-infected macrophages.
    Soares NM; Leal TF; Fiúza MC; Reis EA; Souza MA; Dos-Santos WL; Pontes-de-Carvalho L
    Parasite Immunol; 2010 Apr; 32(4):259-66. PubMed ID: 20398226
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diffuse cutaneous dissemination of visceral leishmaniasis during human immunodeficiency virus (HIV) infection, despite negligible immunodeficiency: repeated failure of liposomal amphotericin B administration, followed by successful long-term pentamidine and paromomycin administration.
    Manfredi R; Marinacci G; Calza L; Passarini B
    Int J Antimicrob Agents; 2008 Jun; 31(6):590-2. PubMed ID: 18456464
    [No Abstract]   [Full Text] [Related]  

  • 31. Successful treatment of post-kala-azar dermal leishmaniasis (PKDL) in a HIV infected patient with multiple relapsing leishmaniasis from Western Europe.
    Rihl M; Stoll M; Ulbricht K; Bange FC; Schmidt RE
    J Infect; 2006 Jul; 53(1):e25-7. PubMed ID: 16274744
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relapsing visceral leishmaniasis in a HIV-1 infected patient with advanced disease.
    Standaert D; Laurent F; Jonckheere S; Scheiff JM; Vandercam B; Yombi JC
    Acta Clin Belg; 2013; 68(2):124-7. PubMed ID: 23967722
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Visceral leishmaniasis: another HIV-associated opportunistic infection? Report of eight cases and review of the literature.
    Altés J; Salas A; Riera M; Udina M; Galmés A; Balanzat J; Ballesteros A; Buades J; Salvá F; Villalonga C
    AIDS; 1991 Feb; 5(2):201-7. PubMed ID: 2031693
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High parasitological failure rate of visceral leishmaniasis to sodium stibogluconate among HIV co-infected adults in Ethiopia.
    Diro E; Lynen L; Mohammed R; Boelaert M; Hailu A; van Griensven J
    PLoS Negl Trop Dis; 2014 May; 8(5):e2875. PubMed ID: 24854196
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A 6 day course of liposomal amphotericin B in the treatment of infantile visceral leishmaniasis: the Italian experience.
    Cascio A; di Martino L; Occorsio P; Giacchino R; Catania S; Gigliotti AR; Aiassa C; Iaria C; Giordano S; Colomba C; Polara VF; Titone L; Gradoni L; Gramiccia M; Antinori S
    J Antimicrob Chemother; 2004 Jul; 54(1):217-20. PubMed ID: 15150166
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Visceral leishmaniasis and HIV infection in the HAART era].
    Marques N; Cabral S; Sá R; Coelho F; Oliveira J; Saraiva da Cunha JG; Meliço Silvestre A
    Acta Med Port; 2007; 20(4):291-8. PubMed ID: 18198072
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of leishmaniasis in HIV-positive patients.
    Laguna F
    Ann Trop Med Parasitol; 2003 Oct; 97 Suppl 1():135-42. PubMed ID: 14678640
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Soluble IL-2 receptor as an agent of serum-mediated suppression in human visceral leishmaniasis.
    Barral-Netto M; Barral A; Santos SB; Carvalho EM; Badaro R; Rocha H; Reed SG; Johnson WD
    J Immunol; 1991 Jul; 147(1):281-4. PubMed ID: 1904902
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of splenectomy in HIV-infected patients with relapsing visceral leishmaniasis.
    Troya J; Casquero A; Muñiz G; Fernández-Guerrero ML; Górgolas M
    Parasitology; 2007 May; 134(Pt 5):621-4. PubMed ID: 17156583
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antimony-induced cerebellar ataxia.
    Khalil EA; Ahmed AE; Musa AM; Hussein MH
    Saudi Med J; 2006 Jan; 27(1):90-2. PubMed ID: 16432602
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.